Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAmbulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment
Clinical Cancer Research, 09/29/09
Maitland ML et al. – Ambulatory blood pressure monitoring detects the blood pressure response to VEGF signaling pathway inhibition by sorafenib during the first 24 hours of treatment. The magnitude of blood pressure elevation is highly variable and unpredictable but could be important in optimizing the therapeutic index of VEGF signaling pathway inhibitor therapy.
Related Articles
Profiles of Serial Changes in Cardiac Troponin T Concentrations and Outcome in Ambulatory Patients With Chronic Heart Failure
JACC - Journal of the American College of Cardiology, 10/26/09
Relevance Score: 66%
Home and ambulatory blood pressure monitoring in chronic kidney disease
Current Opinion in Nephrology and Hypertension, 10/15/09
Relevance Score: 66%
Control of perioperative muscle strength during ambulatory surgery
Current Opinion in Anesthesiology, 11/04/09
Relevance Score: 65%
Ambulatory hernia surgery under local anesthesia is feasible and safe in obese patients
Hernia, 10/30/09
Relevance Score: 65%
Maternal satisfaction and acceptability of foetal electrocardiographic (STAN) monitoring system
Archives of Gynecology and Obstetrics, 11/02/09
Relevance Score: 64%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/18/09
Taurolidine in the prevention and therapy of lung metastases
European Journal of Cardio-Thoracic Surgery, 12/18/09
Oral Chemotherapy in Hormone-Refractory Prostate Carcinoma Patients Unwilling to Be Admitted to Hospital
Urologia Internationalis, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor